<div id="readability-page-1"><p>In a report released today, Graham Doyle from UBS maintained a Buy rating on ConvaTec, with a price target of <span id="expert-recommendation-target">p375.00</span>.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>Doyle covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG &amp; Co. KGaA, Fresenius SE &amp; Co. KGaA, and ConvaTec. According to TipRanks, Doyle has an average return of <span>-2.0%</span> and a 49.66% success rate on recommended stocks. </p> <p>ConvaTec has an analyst consensus of Strong Buy, with a price target consensus of p308.14.</p></div>

CTEC

<p>UBS analyst Graham Doyle maintained a Buy rating on ConvaTec with a price target of p375.00. Doyle, who covers the Healthcare sector, has an average return of -2.0% and a 49.66% success rate on recommended stocks. ConvaTec has a Strong Buy analyst consensus with a price target consensus of p308.14.</p>

ConvaTec (CTEC) Receives a Buy from UBS